Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Notice: Prescription Drug List (PDL): Hyoscine butylbromide August 26, 2016 Our file number: 16-109536-761 The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use…
Notice: Prescription Drug List (PDL): Multiple additions August 26, 2016 Our file number: 16-109523-230 The purpose of this Notice of Amendment is to notify the additions of Asunaprevir, Bilastine, Daratumumab, Elotuzumab, Idarucizumab, Ixekizumab, Olaparib, Osimertinib,…
Notice: Prescription Drug List (PDL): Multiple additions August 9, 2016 Our file number: 16-108811-710 The purpose of this Notice of Amendment is to notify the additions of Alirocumab, Blinatumomab, Brivaracetam, Carfilzomib, Cobimetinib, Elbasvir, Finafloxacin, Grazoprevir,…
Notice: Prescription Drug List (PDL): Naloxone Qualifier Change February 2, 2017 Our file number: 17-101266-74 The purpose of this Notice of Amendment is to notify that Health Canada has revised the Qualifier for Naloxone on the Prescription Drug List. The listing now reads:…
Notice: Prescription Drug List (PDL): Naloxone March 22, 2016 Our file number: 16-103373-445 The purpose of this Notice of Amendment is to notify that as a result of consultation Health Canada has revised the listing for naloxone on the Prescription Drug List (PDL). Health Canada…
Notice - Prescription Drug List (PDL): Ibuprofen February 5, 2016 Our file number: 16-101201-525 The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Ibuprofen to nonprescription status for human…
Notice: Prescription Drug List (PDL): Ibuprofen August 18, 2016 Our file number: 16-109277-453 The purpose of this Notice of Amendment is to notify that Health Canada will switch certain uses of Ibuprofen to nonprescription status for human use by modifying the Human Prescription…
Notice: Prescription Drug List (PDL): Hyoscine butylbromide February 12, 2016 Our file number: 16-101454-524 The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch injectable Hyoscine butylbromide to prescription…
Notice: Prescription Drug List (PDL): Fluticasone propionate February 26, 2016 Our file number: 16-101933-448 The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the…
Notice: Prescription Drug List (PDL): Fluticasone propionate August 26, 2016 Our file number: 16-109530-552 The purpose of this Notice of Amendment is to notify that Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt…
Page 2324 sur 3977Affichage de 23231 à 23240 sur 39762
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
